Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy

Open access

Abstract

Alpha-1 antitrypsin (AAT) deficiency is well-suited as a target for human gene transfer. We performed a phase 1, open-label, dose-escalation clinical trial of a recombinant adeno-associated virus (rAAV) vector expressing normal (M) AAT packaged into serotype 1 AAV capsids delivered by i.m. injection. Nine AAT-deficient subjects were enrolled sequentially in cohorts of 3 each at doses of 6.9 × 10 12 , 2.2 × 10 13 , and 6.0 × 10 13 vector genome particles per patient. Four subjects receiving AAT protein augmentation discontinued therapy 28 or 56 days before vector administration. Vector administration was well tolerated, with only mild local reactions and 1 unrelated serious adverse event (bacterial epididymitis). There were no changes in hematology or clinical chemistry parameters. M-specific AAT was expressed above background in all subjects in cohorts 2 and 3 and was sustained at levels 0.1% of normal for at least 1 year in the highest dosage level cohort, despite development of neutralizing antibody and IFN-γ enzyme-linked immunospot responses to AAV1 capsid at day 14 in all subjects. These findings suggest that immune responses to AAV capsid that develop after i.m. injection of a serotype 1 rAAV vector expressing AAT do not completely eliminate transduced cells in this context.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0904514106

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. 10.1016/s0002-9343(88)80069-x · doi:10.1016/s0002-9343(88)80069-x
  2. A Poirier, et al., Toxicology and biodistribution studies of a recombinant adeno-associated virus 2-α1-antitrypsin vector. Preclinica 2, 43–51 (2004).

Cited by

See all 349

Metadata

Authors
Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., Rouhani, F., Conlon, T. J., Calcedo, R., Betts, M. R., Spencer, C., Byrne, B. J., Wilson, J. M., & Flotte, T. R.
Affiliations
  • University of Florida (US)
  • Applied Genetic Technologies (United States) (US)
  • University of Pennsylvania (US)
  • University of Massachusetts Chan Medical School (US)
  • Boston Children's Hospital (US)
Venue
Proceedings of the National Academy of Sciences
Published
2009-09-22
Volume
106
Issue
38
Pages
16363-16368
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2083867423
Cited by
327
References
31
Citations by year
2026: 12 · 2025: 8 · 2024: 13 · 2023: 16 · 2022: 17 · 2021: 13 · 2020: 11 · 2019: 16 · 2018: 12 · 2017: 20 · 2016: 21 · 2015: 19 · 2014: 24 · 2013: 24 · 2012: 27
FWCI
19.19
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
  • University of Florida
  • Applied Genetic Technologies Corporation
  • National Institutes of Health (and K24, DK047757)
  • National Heart, Lung, and Blood Institute (R01HL69877, P01HL059412, R01HL069877, K24HL004456, K24 HL004456-5)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P01DK058327, P30DK047757, DK58327, DK047757-15)
  • National Center for Research Resources (U42RR016586, M01RR000082)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
alpha-1 antitrypsin deficiency, T cell response, neutralizing antibodies, interferon-gamma, sustained transgene expression, dose escalation
MeSH terms
Dependovirus, Adult, Aged, alpha 1-Antitrypsin, Antibodies, Viral, Capsid, Cell Line, Enzyme-Linked Immunosorbent Assay, Female, Genetic Vectors, Humans, Injections, Intramuscular, Male, Middle Aged, Recombinant Fusion Proteins, T-Lymphocytes, Time Factors, Genetic Therapy, CD4-Positive T-Lymphocytes, Gene Expression, CD8-Positive T-Lymphocytes, alpha 1-Antitrypsin Deficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. https://app.cochat.ai/papers/10.1073/pnas.0904514106
The paper
Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., Rouhani, F., Conlon, T. J., Calcedo, R., Betts, M. R., Spencer, C., Byrne, B. J., Wilson, J. M., & Flotte, T. R. (2009). Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0904514106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.